Transcatheter management of cardiogenic shock in severe aortic stenosis
Frontiers in Cardiovascular Medicine · 29.04.2026 · 13
DOI: 10.3389/fcvm.2026.1803093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 29.04.2026. Verfasst von Francesca Maria Di Muro und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Surgery, and Dentistry, University of Salerno, Salerno, Italy. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Management of cardiogenic shock (CS) in the setting of severe aortic stenosis (AS) remains clinically challenging, owing to the coexistence of fixed valvular obstruction, limited myocardial reserve, and rapidly evolving end-organ hypoperfusion. In this context, early identification of patients unlikely to recover with medical therapy alone and timely transition to definitive valve intervention are critical determinants of outcome. Despite growing clinical experience, decision-making in this setting remains heterogeneous and largely informed by observational evidence. Herein, in the present review, we synthesize contemporary evidence on transcatheter strategies for AS-related CS, with emphasis on clinical decision-making during the acute phase. A physiology-driven approach to early assessment and hemodynamic stabilization is outlined, integrating echocardiography, invasive monitoring, and tailored pharmacologic support to inform escalation pathways. Mechanical circulatory support (MCS) is discussed as a selective, time-limited strategy to achieve stabilization and facilitate procedural planning, while accounting for the unique physiological limitations imposed by fixed valvular obstruction. Available data on balloon aortic valvuloplasty and urgent or emergent transcatheter aortic valve implantation (TAVI) are examined with respect to procedural feasibility, early outcomes, and their positioning within bridging or definitive treatment pathways in CS. Collectively, this work proposes a pathway-oriented framework for AS-related CS that prioritizes early recognition, coordinated multidisciplinary decision-making, and timely progression to definitive valve intervention, tailored to patient risk profile and institutional expertise.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Surgery, and Dentistry, University of Salerno, Salerno, Italy.
- Cardiology Unit, Cardiovascular and Thoracic Department, University Hospital "San Giovanni di Dio e Ruggi d'Aragona", Largo Città di Ippocrate, Salerno, Italy.
- Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy.
- Department of Cardiology, ICOT Istituto Marco Pasquali, Latina, Italy.
- Department of Biomedical Sciences, Humanitas University, Milan, Italy.
- The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
Zitieren
APA
Di Muro, F. M., Sarto, G., Raona, V., Oliva, A., Chiarito, M., Silverio, A., Sciarretta, S., Attisano, T., Vecchione, C., & Galasso, G. (2026). Transcatheter management of cardiogenic shock in severe aortic stenosis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1803093
Vancouver
Di Muro FM, Sarto G, Raona V, Oliva A, Chiarito M, Silverio A, et al. Transcatheter management of cardiogenic shock in severe aortic stenosis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1803093
BibTeX
@article{DiMuro2026,
author = {Di Muro, Francesca Maria and Sarto, Gianmarco and Raona, Valeria and Oliva, Angelo and Chiarito, Mauro and Silverio, Angelo and Sciarretta, Sebastiano and Attisano, Tiziana and Vecchione, Carmine and Galasso, Gennaro},
title = {Transcatheter management of cardiogenic shock in severe aortic stenosis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1803093}
}
EUVIMED